Pneumococcal meningitis in adults: new approaches to management and prevention

@article{Weisfelt2006PneumococcalMI,
  title={Pneumococcal meningitis in adults: new approaches to management and prevention},
  author={Martijn Weisfelt and Jan de Gans and Tom van der Poll and Diederik Beek},
  journal={The Lancet Neurology},
  year={2006},
  volume={5},
  pages={332-342}
}
Since the virtual eradication of meningitis due to Haemophilus influenzae type B by vaccination in the developed world, pneumococcal meningitis has become the leading cause of bacterial meningitis beyond the neonatal period. Clinical and experimental research has increased our knowledge about the pathophysiology and pathogenesis of the disease over the past decades. Despite the availability of effective antibiotics, supportive care facilities, and recent advances in adjunctive strategies-ie… Expand
Bacterial meningitis.
TLDR
The epidemiology, pathophysiology, and management of bacterial meningitis is reviewed, including Dexamethasone therapy, which has been implemented as adjunctive treatment of adults with pneumococcalMeningitis. Expand
Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis
TLDR
The changing epidemiology of bacterial meningitis in the United States and throughout the world is described by reviewing the global changes in etiological agents followed by specific microorganism data on the impact of the development and widespread use of conjugate vaccines. Expand
Pathophysiology of pneumococcal meningitis
TLDR
It is shown that pneumococcal virulence also plays a role in the outcome of pneumococCal meningitis in patients, and the absence of a pneumitiscal arginine synthetase system is associated with favorable outcome in patients. Expand
Drug Insight: adjunctive therapies in adults with bacterial meningitis
TLDR
The pathogenesis and pathophysiology of bacterial meningitis is summarized, the evidence for and against use of the available adjunctive therapies in clinical practice are focused on, and evidence in favor of dexamethasone treatment is focused on. Expand
Invasive Pneumococcal Infections in Finland before Routine Use of Conjugate
TLDR
This study provides a comprehensive picture of the epidemiology of pneumitiscal infections in Finland before the introduction of childhood pneumococcal conjugate vaccines, focusing on disease rates, risk factors, clinical outcome, and healthcare associated infections. Expand
Emergency diagnosis and treatment of adult meningitis.
TLDR
Key diagnostic and therapeutic decisions in the emergency evaluation and treatment of adults with suspected bacterial meningitis are presented and it is important that physicians who prescribe the initial doses of antibiotics in an emergency setting are aware of guidelines for antibiotics and adjunctive steroids. Expand
Bacterial meningitis: a review of effective pharmacotherapy
TLDR
The review presents a brief overview of key clinical and epidemiological aspects of the disease and focuses on advances in pharmacotherapeutic strategies in adult patients with bacterial meningitis in the developed world. Expand
Pathogenesis and Pathophysiology of Pneumococcal Meningitis
TLDR
The most recent views on the pathophysiology of pneumococcal meningitis are discussed, as well as potential targets for (adjunctive) therapy. Expand
Is adjunctive corticosteroid beneficial in pneumococcal meningitis in a region with high rates of resistance to penicillin and ceftriaxone?
TLDR
In conclusion, adjunctive corticosteroids did not affect mortality in adults with pneumococcal meningitis in a region with high rates of resistance to penicillin and ceftriaxone; however, the patients receiving adequate Corticosteroid therapy tended to develop neurologic sequelae less frequently. Expand
Invasive pneumococcal disease; a serious and preventable infection
TLDR
Any infection characterized by the presence of Streptococcus pneumoniae in a body site which is usually sterile, is called invasive pneumococcal disease (IPD), and a large proportion of those serotypes responsible for IPD are covered by the current (and future) pneumococCal vaccines. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 91 REFERENCES
Changing epidemiology of bacterial meningitis in the United States
TLDR
Emergence of antimicrobial resistance in S. pneumoniae has altered the approach to antimicrobial therapy in patients with pneumococcal meningitis, indicating the need to use preventive strategies to reduce the frequency of this serious infection. Expand
Epidemiology of emerging pneumococcal drug resistance: implications for treatment and prevention.
TLDR
The vaccine is underutilized, and a substantial reduction in the morbidity and mortality associated with invasive pneumococcal infections is unlikely until the vaccine is used more widely among persons at risk for disease. Expand
Pathogenesis and pathophysiology of pneumococcal meningitis.
TLDR
A substantial body of evidence that cytokines, chemokines, proteolytic enzymes, and oxidants are involved in the inflammatory cascade that leads to tissue destruction in bacterial meningitis is found. Expand
Pneumococcal vaccines: history, current status, and future directions.
TLDR
Improved utilization of the pneumococcal polysaccharide vaccine and continued development of improved vaccines are essential, and the emergence of drug-resistant strains of S. pneumoniae highlights the importance of preventing pneumitiscal infections by vaccination. Expand
Streptococcus pneumoniae colonisation: the key to pneumococcal disease.
TLDR
The mechanism and epidemiology of colonisation, the complexity of relations within and between species, and the consequences of the different preventive strategies for pneumococcal colonisation are discussed. Expand
Dexamethasone in adults with bacterial meningitis
TLDR
A prospective, randomized, double-blind, multicenter trial of adjuvant treatment with dexamethasone, as compared with placebo, in adults with acute bacterial meningitis. Expand
Pneumococcal conjugate vaccines--a European perspective.
  • R. Reinert
  • Medicine
  • International journal of medical microbiology : IJMM
  • 2004
TLDR
Overall, the development of pneumococcal conjugate vaccines is a significant step in the control of pneumonia, meningitis, and acute otitis media in children in Europe. Expand
Bacterial meningitis--a view of the past 90 years.
  • M. Swartz
  • Medicine
  • The New England journal of medicine
  • 2004
The history of community-acquired bacterial meningitis arguably represents the best example of the salutary effect of the introduction of antimicrobial agents. Before the use of specific antiserums,Expand
Steroids in adults with acute bacterial meningitis: a systematic review.
TLDR
Since treatment with steroids reduces both mortality and neurological sequelae in adults with bacterial meningitis, without detectable adverse effects, routine steroid therapy with the first dose of antibiotics is justified in most adult patients in whom acute community-acquired bacterialMeningitis is suspected. Expand
Bacterial meningitis in the United States in 1995. Active Surveillance Team.
TLDR
Bacterial meningitis in the United States is now a disease predominantly of adults rather than of infants and young children, largely as a result of a 94 percent reduction in the number of cases of H. influenzaeMeningitis due to vaccine-related decline. Expand
...
1
2
3
4
5
...